OOIR: Observatory of International Research

Papers

(The TQCC of Dermatologic Clinics is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)

Article	Citations
Copyright	100
Diversity, Equity, and Inclusion in Dermatology	49
Racial and Ethnic Disparities in Research and Clinical Trials	46
Adnexal and Sebaceous Carcinomas	46
Gender Equity in Medicine and Dermatology in the United States	41
Cutaneous Sarcoidosis	40
Melanoma Staging Systems	27
Educating Dermatologists for the Artificial Intelligence Era	25
Coronavirus Disease 2019 and Race in Dermatology	25
Psoriasis Comorbidities and Their Treatment Impact	24
A Canvas of Contemporary Insights into Clinical Vitiligo	24
Copyright	23
Vascular Anomalies	20
The Psoriasis Treatment Pipeline	20
Contents	20
From Geraniums to Guadalajara on the Virtues of Early Retirement	17
From Clinic to Hospital and Gold Standard to Substandard: The Complexities of Care of Pediatric Patients	16
Copyright	16
Disparities in Care for Psoriasis	15
Copyright	15
Hidradenitis Suppurativa Management with Antibiotics and Systemic Therapies	15
Impact of COVID-19 on Dermatology Residency	14
A Practical Guide to the Diagnosis, Evaluation, and Treatment of Cutaneous T-Cell Lymphoma	14
Using Guidelines of Care to Lower Cardiovascular Risk in Patients with Psoriasis	14
COVID-19 and the Dermatologist	14

Histopathology of Vascular Tumors	13
Copyright	13
Scalp Infection, Inflammation, and Infestation	12
Psoriasis in 2024 and Beyond	12
Pathology of Melanoma	11
Contents	10
Contents	10
Forthcoming Issues	10
Diagnosing Disorders of Facial Erythema	10
Coronavirus Disease 2019 and Dermatology Practice Changes	9
Chemical Peels in Treatment of Melasma	8
Palisaded Neutrophilic Granulomatous Dermatitis, Bowel-Associated Dermatosis–Arthritis Syndrome, and Rheumatoid Neutrophilic Dermatitis	8
The Food and Drug Administration’s Role in Dermatologic Drug Development	8
Contributors	8
Cutaneous Oncology Update	8
Incorporating Cosmetic Procedures into Your Dermatology Practice	7
Cutaneous Oncology in the Immunosuppressed	7
Starting and Maintaining a Successful Dermatology Practice	7
Histopathology of Vascular Malformations	7
Innovations in Acne	6
Copyright	6
Private Equity: the Good	6
Melanoma classification and management in the era of molecular medicine	6
Understanding and Addressing Microaggressions in Medicine	6
Generative Artificial Intelligence in Dermatology	6
Laser-based and Light-based Therapies in Hidradenitis Suppurativa	6
Hidradenitis Suppurativa-Related Autoinflammatory Syndromes	6
Food and Drug Administration’s Role in Dermatology	6
Genomics in Assessing Melanoma Prognosis	6
A Review of Artificial Intelligence in Dermatopathology	6
Innovation in Warts and Molluscum	5
Updates on Lasers in Dermatology	5
Laser Surgery for Dermatologic Conditions in Pediatric Patients	5
Contributors	5
The Role of Sunscreen in Protection from Melanoma	5
Diversity, Equity, and Inclusion in Dermatology Residency	5
Addressing Climate-Related Health Impacts During the Patient Encounter	5
Tips, Tricks, and Pearls to Expertly Treat Common Pediatric Dermatologic Conditions	5
Achieving the Attractive Asian Midface Profile with Hyaluronic Acid–Based Fillers	5
Quality of Life with Neutrophilic Dermatoses	5
Innovation in Dermatomyositis	4
Hot Topics in Cosmetic Dermatology	4
Morbilliform Eruptions in the Hospitalized Child	4
Measuring What Matters to Patients in Dermatology Drug Development	4
Timing of Food Introduction and Allergy Prevention	4
Capillary Malformations	4
Contributors	4
Clinical Patterns and Morphology of COVID-19 Dermatology	4
The Role of Food Allergy in Atopic Dermatitis	4
How Does the Food and Drug Administration Approve Topical Generic Drugs Applied to the Skin?	4

Contributors	4
An Evidence-Based Approach to Pediatric Melanonychia	4
Neutrophilic Panniculitides	4
Contributors	3
Forthcoming Issues	3
Scarring Alopecia	3
Forthcoming Issues	3
How to Be a Successful Businesswoman in Dermatology	3
Paradoxical Psoriasis	3
Hidradenitis Suppurativa	3
Sweet Syndrome and Neutrophilic Dermatosis of the Dorsal Hands	3
Atopic Dermatitis	3
Dermatologic Consequences of Substandard, Spurious, Falsely Labeled, Falsified, and Counterfeit Medications	3
Targeted Therapy and Immunotherapy in Melanoma	3
Neurotoxin in the Lower Third of the Face	3
The Role of Genetics on Psoriasis Susceptibility, Comorbidities, and Treatment Response	3
Neutrophilic Urticarial Dermatosis	3
Collagen Vascular Diseases	3
Cultural Competence and Humility	3
Clinical Decisions in Pediatric Psoriasis	3
Why I’m Still Practicing	3
Immune Checkpoint Inhibitor-Induced Psoriasis	3
Is Private Practice a Possibility for Me?	3
Exploring the Association Between Atopic Dermatitis and Malignancy	3